Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Recurrent local and systemic hypersensitivity reactions after switching back from subcutaneous to intravenous vedolizumab in ulcerative colitis: a case presentation
Saved in:
| Published in: | Gastroenterology Report |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Recurrent local and systemic hypersensitivity reactions after switching back from subcutaneous to intravenous vedolizumab in ulcerative colitis: a case presentation
- Clinical Response and Improvement of the Quality of Life, Fatigue, Mood, and Sleep Disturbances During Vedolizumab Induction Therapy in Polish Patients With Moderate-to-Severe Ulcerative Colitis or Crohn’s Disease
- The Role of Nuclear APOBEC Enzymes in Neoplastic Progression of Ulcerative Colitis
- Comparative effectiveness of mirikizumab and risankizumab in patients with ulcerative colitis: A propensity-matched cohort study
- Use of cyclosporine in acute severe ulcerative colitis with low blood cholesterol level: An early experience
- Real-Life Use of Subcutaneous Biologicals and JAK Inhibitors in IBD Maintenance Therapy: Treatment Continuation, Switching Patterns, and Concomitant Medications
- Eosinophilic Colitis in an Adult Ethiopian Patient